P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
about
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapyExpression analysis of G Protein-Coupled Receptors in mouse macrophagesCell Death in Chondrocytes, Osteoblasts, and OsteocytesLysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival.Development of selective agonists and antagonists of P2Y receptors.Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation.Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.Modeling species-specific diacylglycerol dynamics in the RAW 264.7 macrophage.Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic beta cells.P2Y nucleotide receptors: promise of therapeutic applicationsPyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modificationsActivation of extracellular-signal regulated kinase (ERK1/2) by fluid shear is Ca(2+)- and ATP-dependent in MC3T3-E1 osteoblastsPurinergic signaling is required for fluid shear stress-induced NF-κB translocation in osteoblastsSelective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation.P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.Structure-activity relationships of uridine 5'-diphosphate analogues at the human P2Y6 receptorThe ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.AMP-activated protein kinase as regulator of P2Y(6) receptor-induced insulin secretion in mouse pancreatic β-cellsSynthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor.Pannexin-1 and P2X7-Receptor Are Required for Apoptotic Osteocytes in Fatigued Bone to Trigger RANKL Production in Neighboring Bystander Osteocytes.P2Y6 receptors require an intact cysteinyl leukotriene synthetic and signaling system to induce survival and activation of mast cells.P2 purinergic receptor modulation of cytokine production.Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist.Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.Purinergic signalling in the musculoskeletal system.Detrimental role of the airway mucin Muc5ac during ventilator-induced lung injury.Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.P2X and P2Y nucleotide receptors as targets in cardiovascular disease.Mesenchymal Stem Cells Ageing: Targeting the "Purinome" to Promote Osteogenic Differentiation and Bone Repair.Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survivalNuclear translocation of NF-κB in intact human gut tissue upon stimulation with coffee and roasting products.Activation of transcription factors by extracellular nucleotides in immune and related cell types.P2Y6 Receptor Antagonist MRS2578 Inhibits Neutrophil Activation and Aggregated Neutrophil Extracellular Trap Formation Induced by Gout-Associated Monosodium Urate Crystals.The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.The P2X7 Receptor is an Important Regulator of Extracellular ATP Levels.Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women.Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB.
P2860
Q24629255-8EAF929E-F21F-4B66-9FFD-9719DC88D603Q24650905-82033434-EBBF-41E8-A951-4272199226A8Q28067045-E1BA673F-B8D9-474F-9C1C-8DB6730E7A35Q30495949-58903A88-221E-45D6-8D3F-718C27D7E18CQ33348980-47345022-69EC-4C65-982F-15366DFA6B98Q33370824-3472597E-2779-4E94-9483-0CC28FAAE7CFQ33636713-CF4763CF-590C-454D-B8A2-BAF5A082E5EFQ33653983-4FA17B85-97F9-4E25-96D9-3490C10BB7D7Q33828185-63D51FB8-B635-498E-8504-959962A67140Q34062142-0674B071-496B-412E-99B6-A16B73718213Q34109265-DDB1D0C6-9E30-4305-AC69-841F9844576DQ34118986-7C02BE8A-20CF-48F5-A612-E0B35B16F00DQ34629041-86A40380-2BC9-4A78-8A7D-7CC8E700F426Q34707637-5C328E2E-1255-4B27-944B-22D94FF214A3Q35163180-93528970-E47D-45EB-A256-7ED007089EA2Q36116884-51E36525-B32F-476B-A640-BB0C11562204Q36290218-A7137FA2-6169-4E33-B030-BA4771F2A190Q36674463-FC434337-0413-4DD7-80D7-7F3918DBC3CEQ36790061-E2C578E7-E3F8-4962-92DB-566F50F80FB9Q36863544-10A1CFB0-D789-40ED-89BD-3D12B4DFD8BEQ37024767-2F591ED6-6FC1-422A-AC15-797BAD862835Q37041271-C226D682-5DAC-4517-9A7C-C847F3E67A16Q37135491-EAA8E022-69FA-49D3-9437-223DDCE4277CQ37337859-C3201C70-DA4E-4D73-9DED-2186427B245BQ37462648-8B330AEE-8E6F-4788-B302-190D1ADA86E9Q37468714-1244A99A-1152-4EC4-AED8-3B573A4D6936Q37472011-53995BFB-998A-4677-94A4-FBF39D141DA4Q37713745-B66CF982-E9D0-4666-9EC3-6DCB2FF8CAB3Q38089738-1B23BC09-FE25-4937-831B-659196DA39A5Q38692744-C4F20138-08CD-4D0E-925F-3151568E7240Q39246166-35725744-0103-45E4-A3C2-C0BBF9A5C841Q39476847-970399FA-E2D2-406D-82E2-A7EB82749D3FQ40103919-04F37C5F-6B6F-4042-9F9E-8A5C1B5FFE43Q40428922-0ACB188A-5AB6-468B-B130-A4B58D82879AQ42020494-37B3243C-509B-428B-AEF1-0A85A4EBB447Q42106964-BD029B07-A12D-4254-8E8C-FF0730ACC67CQ42150686-E816EB7E-DC39-4D6D-9B77-4E87532509DEQ43514279-51BCF5C8-B216-4CB0-BF0B-8191E162B262Q44503709-A0967094-F20C-4ABC-AB76-81F001C31132Q46113968-76CB0C41-66F3-440A-B2C6-DACA606260CB
P2860
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
@en
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
@nl
type
label
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
@en
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
@nl
prefLabel
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
@en
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
@nl
P2093
P2860
P356
P1476
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
@en
P2093
Jasminka Korcok
Lin N Raimundo
S Jeffrey Dixon
Stephen M Sims
Xiaobing Du
P2860
P304
16909-16915
P356
10.1074/JBC.M410764200
P407
P577
2005-02-18T00:00:00Z